ID   RISB_YERP3              Reviewed;         156 AA.
AC   A7FLE8;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   11-SEP-2007, sequence version 1.
DT   10-FEB-2021, entry version 76.
DE   RecName: Full=6,7-dimethyl-8-ribityllumazine synthase {ECO:0000255|HAMAP-Rule:MF_00178};
DE            Short=DMRL synthase {ECO:0000255|HAMAP-Rule:MF_00178};
DE            Short=LS {ECO:0000255|HAMAP-Rule:MF_00178};
DE            Short=Lumazine synthase {ECO:0000255|HAMAP-Rule:MF_00178};
DE            EC=2.5.1.78 {ECO:0000255|HAMAP-Rule:MF_00178};
GN   Name=ribH {ECO:0000255|HAMAP-Rule:MF_00178};
GN   OrderedLocusNames=YpsIP31758_3116;
OS   Yersinia pseudotuberculosis serotype O:1b (strain IP 31758).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Yersiniaceae; Yersinia.
OX   NCBI_TaxID=349747;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=IP 31758;
RX   PubMed=17784789; DOI=10.1371/journal.pgen.0030142;
RA   Eppinger M., Rosovitz M.J., Fricke W.F., Rasko D.A., Kokorina G.,
RA   Fayolle C., Lindler L.E., Carniel E., Ravel J.;
RT   "The complete genome sequence of Yersinia pseudotuberculosis IP31758, the
RT   causative agent of Far East scarlet-like fever.";
RL   PLoS Genet. 3:1508-1523(2007).
CC   -!- FUNCTION: Catalyzes the formation of 6,7-dimethyl-8-ribityllumazine by
CC       condensation of 5-amino-6-(D-ribitylamino)uracil with 3,4-dihydroxy-2-
CC       butanone 4-phosphate. This is the penultimate step in the biosynthesis
CC       of riboflavin. {ECO:0000255|HAMAP-Rule:MF_00178}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2S)-2-hydroxy-3-oxobutyl phosphate + 5-amino-6-(D-
CC         ribitylamino)uracil = 6,7-dimethyl-8-(1-D-ribityl)lumazine + H(+) + 2
CC         H2O + phosphate; Xref=Rhea:RHEA:26152, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15934, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:58201, ChEBI:CHEBI:58830; EC=2.5.1.78;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_00178};
CC   -!- PATHWAY: Cofactor biosynthesis; riboflavin biosynthesis; riboflavin
CC       from 2-hydroxy-3-oxobutyl phosphate and 5-amino-6-(D-
CC       ribitylamino)uracil: step 1/2. {ECO:0000255|HAMAP-Rule:MF_00178}.
CC   -!- SUBUNIT: Forms an icosahedral capsid composed of 60 subunits, arranged
CC       as a dodecamer of pentamers. {ECO:0000255|HAMAP-Rule:MF_00178}.
CC   -!- SIMILARITY: Belongs to the DMRL synthase family. {ECO:0000255|HAMAP-
CC       Rule:MF_00178}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP000720; ABS49790.1; -; Genomic_DNA.
DR   RefSeq; WP_002208666.1; NC_009708.1.
DR   SMR; A7FLE8; -.
DR   EnsemblBacteria; ABS49790; ABS49790; YpsIP31758_3116.
DR   GeneID; 49787009; -.
DR   GeneID; 57975531; -.
DR   KEGG; ypi:YpsIP31758_3116; -.
DR   HOGENOM; CLU_089358_1_1_6; -.
DR   OMA; CQGVTQG; -.
DR   UniPathway; UPA00275; UER00404.
DR   Proteomes; UP000002412; Chromosome.
DR   GO; GO:0009349; C:riboflavin synthase complex; IEA:InterPro.
DR   GO; GO:0000906; F:6,7-dimethyl-8-ribityllumazine synthase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0009231; P:riboflavin biosynthetic process; IEA:UniProtKB-UniRule.
DR   CDD; cd09209; Lumazine_synthase-I; 1.
DR   Gene3D; 3.40.50.960; -; 1.
DR   HAMAP; MF_00178; Lumazine_synth; 1.
DR   InterPro; IPR034964; LS.
DR   InterPro; IPR002180; LS/RS.
DR   InterPro; IPR036467; LS/RS_sf.
DR   PANTHER; PTHR21058; PTHR21058; 1.
DR   Pfam; PF00885; DMRL_synthase; 1.
DR   SUPFAM; SSF52121; SSF52121; 1.
DR   TIGRFAMs; TIGR00114; lumazine-synth; 1.
PE   3: Inferred from homology;
KW   Riboflavin biosynthesis; Transferase.
FT   CHAIN           1..156
FT                   /note="6,7-dimethyl-8-ribityllumazine synthase"
FT                   /id="PRO_1000058373"
FT   REGION          57..59
FT                   /note="5-amino-6-(D-ribitylamino)uracil binding"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00178"
FT   REGION          81..83
FT                   /note="5-amino-6-(D-ribitylamino)uracil binding"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00178"
FT   REGION          86..87
FT                   /note="1-deoxy-L-glycero-tetrulose 4-phosphate binding"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00178"
FT   ACT_SITE        89
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00178"
FT   BINDING         22
FT                   /note="5-amino-6-(D-ribitylamino)uracil"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00178"
FT   BINDING         114
FT                   /note="5-amino-6-(D-ribitylamino)uracil; via amide nitrogen
FT                   and carbonyl oxygen"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00178"
FT   BINDING         128
FT                   /note="1-deoxy-L-glycero-tetrulose 4-phosphate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00178"
SQ   SEQUENCE   156 AA;  16197 MW;  504815322C8C83E7 CRC64;
     MNVIEGVVAT PNARVAIAIA RFNNFINDSL LDGAIDALKR IGQVSDDNIT VVWVPGAYEL
     PLVANVLAKT NRYDAVIALG TVIRGGTAHF EYVAGEASSG LSSVAMNSDI PVAFGVLTTE
     SIEQAIERAG TKAGNKGAEA ALTALEMINV IKAIKG
//
